JP2009080118A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009080118A5 JP2009080118A5 JP2008259812A JP2008259812A JP2009080118A5 JP 2009080118 A5 JP2009080118 A5 JP 2009080118A5 JP 2008259812 A JP2008259812 A JP 2008259812A JP 2008259812 A JP2008259812 A JP 2008259812A JP 2009080118 A5 JP2009080118 A5 JP 2009080118A5
- Authority
- JP
- Japan
- Prior art keywords
- muramyl dipeptide
- protein
- adjuvant composition
- microparticles
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2819496P | 1996-10-10 | 1996-10-10 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10517749A Division JP2001502315A (ja) | 1996-10-10 | 1997-10-10 | ウイルス感染を処置するための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009080118A JP2009080118A (ja) | 2009-04-16 |
| JP2009080118A5 true JP2009080118A5 (https=) | 2010-01-28 |
Family
ID=21842081
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10517749A Ceased JP2001502315A (ja) | 1996-10-10 | 1997-10-10 | ウイルス感染を処置するための組成物および方法 |
| JP2008259812A Pending JP2009080118A (ja) | 1996-10-10 | 2008-10-06 | ウイルス感染を処置するための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10517749A Ceased JP2001502315A (ja) | 1996-10-10 | 1997-10-10 | ウイルス感染を処置するための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (6) | US6043347A (https=) |
| EP (1) | EP0939835A4 (https=) |
| JP (2) | JP2001502315A (https=) |
| KR (2) | KR100667121B1 (https=) |
| CN (1) | CN1327896C (https=) |
| AU (1) | AU732809B2 (https=) |
| BR (1) | BR9712289A (https=) |
| CA (1) | CA2268372C (https=) |
| MX (1) | MXPA02010374A (https=) |
| NZ (1) | NZ334941A (https=) |
| WO (1) | WO1998015658A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1327896C (zh) * | 1996-10-10 | 2007-07-25 | 探针国际公司 | 治疗病毒感染的组合物及方法 |
| US7157091B1 (en) * | 1999-06-18 | 2007-01-02 | Ludwig Institute For Cancer Research | MAGE-A1 peptides presented by HLA class II molecules |
| US6599441B1 (en) * | 2000-07-18 | 2003-07-29 | Emerald Biostructures, Inc. | Crystallization solutions |
| CN1339319A (zh) * | 2000-08-18 | 2002-03-13 | 清华大学 | 一种治疗艾滋病的药物及其制备方法 |
| US6987184B2 (en) * | 2001-02-15 | 2006-01-17 | Signal Pharmaceuticals, Llc | Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| US20040203084A1 (en) * | 2003-04-10 | 2004-10-14 | Doug Levinson | Profiling conformational variants, antibody compositions and methods of using the same |
| US7206991B2 (en) * | 2003-10-15 | 2007-04-17 | Lsi Logic Corporation | Method, apparatus and program for migrating between striped storage and parity striped storage |
| US7311928B2 (en) * | 2003-12-09 | 2007-12-25 | Briant Burke | Topical compositions containing tea tree oil for treatment of viral lesions |
| US7723063B2 (en) * | 2004-04-28 | 2010-05-25 | Intrinsic Lifesciences | Methods for measuring levels of bioactive human hepcidin |
| WO2006023774A2 (en) * | 2004-08-20 | 2006-03-02 | Imquest Biosciences, Inc. | Plasma or serum fraction for treatment and prevention of viral infections and related conditions |
| MX2007008497A (es) * | 2005-01-13 | 2007-09-14 | Novartis Vaccines & Diagnostic | Ensayos inmunosorbentes enlazados a enzimas usando reactivos de peptidos especificos de prion. |
| EP1855112A1 (en) * | 2006-05-10 | 2007-11-14 | Inserm | Method for the in vitro screening of compounds inhibiting production of infectious HIV-1 virions |
| US8200520B2 (en) | 2007-10-03 | 2012-06-12 | International Business Machines Corporation | Methods, systems, and apparatuses for automated confirmations of meetings |
| JP5662309B2 (ja) * | 2008-04-01 | 2015-01-28 | イネイト・イムノセラピューティクス・リミテッド | 腫瘍性疾患を治療するための組成物および方法 |
| WO2009123480A1 (en) | 2008-04-01 | 2009-10-08 | Virionyx Corporation Ltd | Anti-infective agents and uses thereof |
| NZ571665A (en) | 2008-09-30 | 2011-01-28 | Innate Therapeutics Ltd | Compositions and methods for treatment of radiation exposure utilising cross-linked muramyl dipeptide microparticles |
| WO2010134305A1 (ja) | 2009-05-18 | 2010-11-25 | 国立大学法人東京医科歯科大学 | Ｈｉｖ立体構造認識抗体誘導ペプチド抗原、及びその合成方法 |
| NZ577731A (en) * | 2009-06-16 | 2010-08-27 | Innate Therapeutics Ltd | Compositions and methods for treatment of multiple sclerosis |
| EP2550362B1 (en) | 2010-03-25 | 2017-01-04 | Oregon Health&Science University | Cmv glycoproteins and recombinant vectors |
| RU2517084C2 (ru) * | 2010-08-06 | 2014-05-27 | Олег Ильич Эпштейн | Способ и средство для ингибирования продукции или усиления элиминации белка р24 |
| US20140056935A1 (en) | 2011-04-04 | 2014-02-27 | National University Corporation Tokyo Medical And Dental University | Peptide which can induce antibody capable of recognizing stereostructure of hiv |
| CA2832109C (en) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
| EP2568289A3 (en) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
| US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
| EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
| EP2848937A1 (en) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Methods of identifying novel HIV-1 immunogens |
| US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| WO2017093985A1 (en) * | 2015-12-05 | 2017-06-08 | Centre Hospitalier Universitaire Vaudois | Hiv binding agents |
| CN108997482B (zh) * | 2018-08-09 | 2025-09-09 | 东莞市朋志生物科技有限公司 | 用于检测hiv-1的合成肽 |
| JP7678790B2 (ja) * | 2019-07-15 | 2025-05-16 | ローザンヌ ユニヴァーシティ ホスピタル | Ｈｉｖ結合剤 |
| WO2022152939A1 (en) | 2021-01-18 | 2022-07-21 | Conserv Bioscience Limited | Coronavirus immunogenic compositions, methods and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5528933A (en) * | 1978-08-21 | 1980-02-29 | Dai Ichi Seiyaku Co Ltd | Muramyldipeptide dimer |
| CA1341482C (en) * | 1984-10-31 | 2005-05-10 | Paul A. Luciw | Process for preparing fragments of aids-associated retroviruses |
| US4946945A (en) * | 1987-06-23 | 1990-08-07 | Allergy Immuno Technologies, Inc. | Immunotherapy agents for treatment of IgE mediated allergies |
| US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
| CA2025634A1 (en) * | 1989-09-19 | 1991-03-20 | Thomas Fuerst | Peptides including ctl epitopes of hiv proteins and use thereof |
| US6565842B1 (en) | 1995-06-07 | 2003-05-20 | American Bioscience, Inc. | Crosslinkable polypeptide compositions |
| CN1327896C (zh) * | 1996-10-10 | 2007-07-25 | 探针国际公司 | 治疗病毒感染的组合物及方法 |
-
1997
- 1997-10-10 CN CNB971987432A patent/CN1327896C/zh not_active Expired - Lifetime
- 1997-10-10 AU AU48131/97A patent/AU732809B2/en not_active Expired
- 1997-10-10 CA CA2268372A patent/CA2268372C/en not_active Expired - Lifetime
- 1997-10-10 US US08/948,782 patent/US6043347A/en not_active Expired - Lifetime
- 1997-10-10 WO PCT/US1997/018257 patent/WO1998015658A1/en not_active Ceased
- 1997-10-10 KR KR1020057016920A patent/KR100667121B1/ko not_active Expired - Lifetime
- 1997-10-10 MX MXPA02010374A patent/MXPA02010374A/es active IP Right Grant
- 1997-10-10 KR KR1019997003052A patent/KR100547049B1/ko not_active Expired - Lifetime
- 1997-10-10 NZ NZ334941A patent/NZ334941A/xx not_active IP Right Cessation
- 1997-10-10 BR BR9712289-0A patent/BR9712289A/pt not_active Application Discontinuation
- 1997-10-10 JP JP10517749A patent/JP2001502315A/ja not_active Ceased
- 1997-10-10 EP EP97910856A patent/EP0939835A4/en not_active Withdrawn
-
2000
- 2000-01-14 US US09/482,612 patent/US6258599B1/en not_active Expired - Lifetime
- 2000-10-02 US US09/677,554 patent/US6335017B1/en not_active Expired - Lifetime
-
2001
- 2001-11-05 US US09/985,581 patent/US6670181B2/en not_active Expired - Lifetime
-
2003
- 2003-10-28 US US10/695,112 patent/US20040141996A1/en not_active Abandoned
-
2006
- 2006-11-28 US US11/605,017 patent/US8110203B2/en not_active Expired - Fee Related
-
2008
- 2008-10-06 JP JP2008259812A patent/JP2009080118A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009080118A5 (https=) | ||
| Chattopadhyay et al. | Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation | |
| Yan et al. | Current applications and future prospects of nanotechnology in cancer immunotherapy | |
| Bal et al. | Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations | |
| JP2010527906A5 (https=) | ||
| JP2012505245A5 (https=) | ||
| CN103037898B (zh) | 呼吸道合胞病毒抗原组合物和方法 | |
| CN1237102A (zh) | 脂质体 | |
| JP2012505249A5 (https=) | ||
| JP2006504653A5 (https=) | ||
| JP2002540077A5 (https=) | ||
| Zhao et al. | Intranasal immunization with O-2′-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens | |
| US9925252B2 (en) | Antigenic compositions and methods | |
| JP2018536002A5 (https=) | ||
| CN104244971A (zh) | 抗疟疾微颗粒疫苗 | |
| CN1549728A (zh) | 在可生物降解的微球体中含有抗原、基因载体和佐剂的免疫组合物 | |
| JP2021042193A5 (https=) | ||
| JP6934862B2 (ja) | 抗マラリア組成物および方法 | |
| JP2004504260A5 (https=) | ||
| CN1464789A (zh) | 抗流感病毒疫苗及所述病毒疫苗的制备方法 | |
| JPH05504756A (ja) | 免疫刺激性を有する組成物と、そのヒトと獣医学用医薬への応用 | |
| CN118045171A (zh) | 一种基于两种金属佐剂的纳米疫苗递送系统及其制备方法 | |
| Foyez et al. | Nanotechnology in vaccine development and constraints | |
| CN113226365A (zh) | 纳米卫星复合物 | |
| Rosales-Mendoza et al. | Chitosan-based mucosal nanovaccines |